Press Releases
Cell-Based Therapies Show Promise for Seriously Ill Patients with COVID-19: Federal Funding for Large-Scale, Randomized, Controlled Trials is Needed to Confirm Results and Help Bring Safe and Effective Treatments to Patients in Need
Washington, DC (March 24, 2021) – A new report released by Alliance for Cell Therapy Now, an independent, non-profit organization guided by leaders representing academic and medical institutions, industry innovators, and patients, summarizes clinical studies that are...
The Case for Federal Investment in Cell-Based Therapies for Patients with COVID-19
A new report released by Alliance for Cell Therapy Now, an independent, non-profit organization guided by leaders representing academic and medical institutions, industry innovators, and patients, summarizes clinical studies that are now underway that explore the use...
Alliance for Cell Therapy Now Commends Congress for Regenerative Medicine and Cell Therapy Provisions in FY 2021 Spending Bill: Additional Support for Clinical Trials for COVID Patients is Still Needed
Washington, DC (December 30, 2020) – Leaders of Alliance for Cell Therapy Now (ACT Now)—including representatives of academic and medical institutions, industry innovators, and patients—applaud Congress for its inclusion of important provisions in the final FY 2021...
Former NFL Players Show Interest in Regenerative Medicine and Cell Therapies
Mount Laurel, NJ (October 14, 2020) – The National Football League Alumni Association (NFLA) today released a report exploring the interest in and use of regenerative medicine and cell therapies (RMCTs) for conditions of interest to NFLA members. “We are thrilled...
FDA Approves Study to Investigate the Use of Cell Therapy to Treat COVID-19 Related Multisystem Inflammatory Syndrome in Children (MIS-C)
New York, NY (September 16, 2020) – The Cura Foundation in collaboration with The Marcus Foundation, Sanford Health and Alliance for Cell Therapy Now, is supporting a clinical trial of human cord tissue mesenchymal stromal cells (hCT-MSC) to treat children with...
MSC Therapy for Acute Respiratory Distress Syndrome; It’s Time to Accelerate Clinical Trials for COVID-19 Patients in Need
Washington, DC (June 3, 2020) – A new systematic review and meta-analysis of clinical studies using mesenchymal stromal cells (MSCs) led by a team at the Mayo Clinic, and including researchers from Emory, Duke, Case-Western, and...
New Report Calls for Measurement of Outcomes and Federal Funding for Research and Increased Capacity at FDA to Advance Safe and Effective Regenerative Cell Therapies
Washington, D.C. (December 10, 2019) – A new report released by the independent, non-profit Alliance for Cell Therapy Now, highlights the need for a national effort to measure outcomes related to regenerative cell therapies, as well as increased federal funding for...
Regenerative Cell Therapies: Making Safe and Effective Treatments Available to Patients, December 2019
The Alliance for Cell Therapy Now hosted a briefing in the Senate Hart Office Building on Capitol Hill on September 19, 2019, in collaboration with the Regenerative Medicine Foundation and the Cord Blood Association. During the event, public and private sector leaders...
Alliance for Cell Therapy Now Hosts Briefing on Capitol Hill: Regenerative Cell Therapies: Making Safe and Effective Treatments Available to Patients
Washington, D.C. (September 19, 2019) – Today, the Alliance for Cell Therapy Now hosted a briefing in Senate Hart Office Building on Capitol Hill to raise awareness of the actions needed to make safe and effective treatments available to patients in collaboration with...